Thiotepa

FDA Approved: * March 9, 1959
Pharm Company: * IMMUNEX
Category: Cancer

Thiotepa (INN[3]), sold under the brand name Tepadina, is a medication used to treat cancer.[1][2][4] Thiotepa is an organophosphorus compound with the formula (C2H4N)3PS.[5] It is an analog of N,N′,N′′-triethylenephosphoramide (TEPA), which contains tetrahedral phosphorus and is structurally akin to phosphate. It is manufactured by heating aziridine with thiophosphoryl chloride.[citation... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 0143-9309
Labeler:
West-ward Pharmaceuticals Corp
Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 0143-9565
Labeler:
West-ward Pharmaceutical Corp
Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 25021-246
Labeler:
Sagent Pharmaceuticals
Thiotepa 15 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 43598-650
Labeler:
Dr.reddy's Laboratories Inc.,
Tepadina 15 mg/1 Intravenous Injection, Powder, for Solution
NDC: 53964-001
Labeler:
Adienne Sa
Tepadina 100 mg/1 Intravenous Injection, Powder, for Solution
NDC: 53964-002
Labeler:
Adienne Sa
Thiotepa 15 mg/15mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 54879-014
Labeler:
Sti Pharma LLC
Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 55390-030
Labeler:
Bedford Laboratories
Thiotepa 100 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 65219-029
Labeler:
Fresenius Kabi USA, LLC
Thiotepa 15 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
NDC: 68083-446
Labeler:
Gland Pharma Limited

Related Brands

Drugs with the same active ingredients